Investors in Ev

mentorDay is a non-profit, independent startup accelerator that supports entrepreneurs worldwide through fully funded, online acceleration programs. With 30+ years of experience and over 3,200 startups accelerated across 40 countries, it is one of the most active accelerators globally. Backed by a community of 1,200+ mentors, mentorDay helps founders validate, grow, and access funding through practical, intensive programs, with no cost or equity required.

We work with innovative partners to invest in, accelerate and incubate the most disruptive startups and pioneering founders. Our team of seasoned venture capitalists and operational partners empower smart capital and founders and put their startups on the path of faster and greater growth.

The MVC manages a €10 million fund by investing equity in start-up companies operating within the digital economy and innovative economic sectors that contribute significant value to the Maltese economy. Eligible companies may include those involved in video game development, fintech, e-sports, life sciences, pharma, green energy, the filming industry, agritech, AI, communications, electronics, financial services, medical devices, software, bluewater industries, and digital technology. Start-up companies operating in innovative economic sectors will have access to the newly established fund, with each start-up being eligible for up to €500,000 in the form of equity investment. The investment by the fund will be pari-passu with that of private venture capital investors. The Malta Government Venture Capital Limited will be the sole entity responsible for administering this scheme.

Vivalto Partners is an independent European management company approved by the Autorité des Marchés Financiers, specializing in investment in the healthcare sector. We invest in profitable SMEs and mid-cap companies and support their managers in their development projects, in capital and through strategic and operational support. Founded in 2021 by Daniel Caille, a pioneering figure in private healthcare in France, Vivalto Partners brings together healthcare experts and investment professionals in an approach to supporting players who contribute to the quality of care to meet the major challenges of transforming the sector in Europe.

GENEO Capital Entrepreneur is dedicated to enabling positive finance for the real economy. Specializing in investing in and supporting the growth of Small and Medium-sized Enterprises (SMEs) and Intermediate-sized Enterprises (SMIs), GENEO focuses on fostering their long-term development projects. With a mission-driven approach, GENEO seeks to contribute to sustainable economic growth by providing capital and strategic support to SMEs and SMIs. This includes partnering with ambitious entrepreneurs to scale their businesses, drive innovation, and create lasting value. Through its commitment to the real economy, GENEO aims to make a meaningful impact by empowering businesses to thrive and succeed in their growth journeys.

Alven is an independent early-stage venture capital firm managing over $500m, known for backing 130+ startups across 20 years. They focus on supporting European startups with global potential, specializing in sectors like B2C/B2B marketplaces, productivity tools, AI platforms, social & entertainment, financial services, and wellness brands. Some notable investments include Akeneo, Dataiku, Algolia, Happn, MeilleursAgents, and Birchbox. Alven actively seeks innovative startups at the Series A or Seed stage to partner with for long-term success and growth.

We're Eutopia, a Paris and New York based early-stage venture capital fund. We invest in consumer startups that are rethinking the way we eat, sleep, dress, exercise, and feel. We empower early-stage startups to grow through investment, in-house expertise, and a network of global advisors. With Europe as our investment playground, and the US as our second home, we invest at seed/series A stage in rounds from €500,000 to €10 million.

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world's most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies.

Five Seasons Ventures is the premier pan-European Venture Capital fund focused on consumer brands, specializing in food-tech investments across the value chain to foster a healthier, more efficient, and sustainable system. We seek future category leaders exhibiting high growth potential, proven technology, and early commercial traction, typically at Series A or B stages. However, we also consider pre-revenue companies with exceptional promise at the Seed stage. Our initial investment ranges from €2-10 million, securing a significant minority stake and a board seat. We prefer syndicated investments with value-add investors and can deploy up to €20 million per company. With a team boasting over 40 years of cumulative VC experience, including 15+ years in food and ag investing, and over 30 years of operational expertise in the industry, we bring deep insights and networks to our portfolio. Supported by strategic and financial investors, we provide access to critical business and financing opportunities. As long-term investors, we leverage our industry knowledge to create enduring value and aim for successful exits for our portfolio companies.

Inovexus positions itself as a cross-border acceleration fund platform focused on early-stage B2B tech startups that aspire to expand globally. Their mission centers on providing founders with essential resources such as capital, mentorship, and strategic guidance. This support aims to empower startups to scale internationally and navigate the competitive terrain of the technology industry effectively. For further details about Inovexus and their investment approach, you can visit their official website at Inovexus.

The Santon Group, we are a distinguished property investment and development company based in the UK, specializing in residential and commercial real estate ventures. Our portfolio focuses on strategic locations across the country, where we are recognized for our commitment to delivering high-quality developments that enhance urban landscapes and community living. Our approach blends modern design with sustainable practices, ensuring our projects meet contemporary standards while minimizing environmental impact. Collaborating closely with top architects, contractors, and local authorities, we prioritize innovation and excellence in every aspect of development, from concept to completion. Committed to community engagement, we actively involve local stakeholders to create sustainable, thriving environments that support economic growth and enrich the lives of residents and businesses alike. Looking forward, The Santon Group continues to pursue new opportunities and uphold our values of integrity, quality, and responsible urban development.

Agronomics is an investment business specializing in environmentally sustainable opportunities within the growing food industry. They focus on supporting ventures that innovate in sustainable agriculture, alternative proteins, and other technologies that promote ecological responsibility in food production. Agronomics' investment strategy is guided by a commitment to fostering positive environmental impact while generating financial returns. By partnering with pioneering companies in the food sector, Agronomics aims to advance sustainable practices and contribute to the global shift towards more sustainable food production systems.